GSK's cancer drug Jemperli delivers positive phase three results
- Positive results from trial of cancer drug Jemperli - Regulatory submissions expected in H1 - Sales expected to reach £100-£150m by 2027Pharmaceutical company GSK (GSK) said a late-stage trial of its cancer drug Jemperli used in...
28 March 2023